| Patient characteristic . | Intervention (N = 67) . | Control (N = 67) . | Total (N = 134) . | P-value . |
|---|---|---|---|---|
| Age (mean, SD) | 62.5 (8.5) | 61.1 (9.9) | 61.8 (9.2) | .37 |
| Gender | .86 | |||
| Men | 44 (65.7%) | 42 (62.7%) | 86 (64.2%) | |
| Women | 23 (34.3%) | 25 (37.3%) | 48 (35.8%) | |
| Paid job | .86 | |||
| Yes | 22 (32.8%) | 24 (35.8%) | 46 (34.3%) | |
| No | 45 (67.2%) | 43 (64.2%) | 88 (65.7%) | |
| Marital status | .57 | |||
| Married/living together | 49 (73.1%) | 45 (67.2%) | 94 (70.1%) | |
| Unmarried/divorced/widowed | 18 (26.9%) | 22 (32.8%) | 40 (29.9%) | |
| Years of education | .29 | |||
| 5-10 | 33 (49.3%) | 24 (35.8%) | 57 (42.5%) | |
| 11-16 | 30 (44.7%) | 38 (56.7%) | 68 (50.8%) | |
| 17-21 | 4 (6.0%) | 5 (7.5%) | 9 (6.7%) | |
| Tumor location | .079 | |||
| Lip/oral/cavity/oropharynx | 29 (43.3%) | 42 (62.7%) | 71 (53%) | |
| Hypopharynx/larynx | 21 (31.3%) | 14 (20.9%) | 35 (26.1%) | |
| Other head and neck cancers | 17 (25.4%) | 11 (16.4%) | 28 (20.9%) | |
| Tumor stage | .22 | |||
| Unknown | 7 (10.4%) | 2 (3.0%) | 9 (6.7%) | |
| I | 13 (19.4%) | 17 (25.4%) | 30 (22.4%) | |
| II | 15 (22.4%) | 9 (13.4%) | 24 (17.9%) | |
| III | 9 (13.4%) | 13 (19.4%) | 22 (16.4%) | |
| IV | 23 (43.3%) | 26 (38.8%) | 49 (36.6%) | |
| Tumor treatment | .005 | |||
| Surgery | 11 (16.4%) | 19 (28.4%) | 30 (22.4%) | |
| Radiotherapy | 22 (32.8%) | 12 (17.9%) | 34 (25.4%) | |
| Chemoradiation | 5 (7.5%) | 18 (26.9%) | 23 (17.2%) | |
| Surgery + radiotherapy | 25 (37.3%) | 14 (20.9%) | 39 (29.1%) | |
| Surgery + chemoradiation | 4 (6.0%) | 3 (4.4%) | 7 (5.2%) | |
| Surgery + chemotherapy | 0 | 1 (1.5%) | 1 (0.7%) | |
| Time since treatment | .65 | |||
| >7 months | 26 (38.8%) | 23 (34.3%) | 49 (36.6%) | |
| 7-12 months | 10 (14.9%) | 14 (20.9%) | 24 (17.9%) | |
| >12 months | 31 (46.3%) | 30 (44.8%) | 61 (45.5%) | |
| Anxiety or depression disorder (CIDI) | .42 | |||
| Yes | 14 (20.9%) | 19 (28.4%) | 33 (24.6%) | |
| No | 53 (79.1%) | 48 (71.6%) | 101 (75.4%) | |
| HADS (mean, SD) | ||||
| Total | 17.5 (5.2) | 19.5 (5.8) | 18.5 (5.6) | .030 |
| Depression | 8.28 (3.6) | 9.96 (3.7) | 9.62 (3.6) | .009 |
| Anxiety | 9.18 (3.6) | 9.58 (3.7) | 9.38 (3.7) | .53 |
| EORTC QLQ-C30 (mean, SD) | ||||
| Global quality of life | 59.5 (19.8) | 55.5 (19.5) | 57.46 (19.7) | .24 |
| Physical functioning | 71.6 (20.9) | 70.7 (20.8) | 71.16 (20.8) | .79 |
| Role functioning | 62.2 (26.7) | 55.5 (26.0) | 58.83 (26.5) | .14 |
| Emotional functioning | 58.3 (26.1) | 56.3 (22.6) | 57.30 (24.3) | .65 |
| Cognitive functioning | 71.4 (27.3) | 70.6 (24.5) | 71.02 (25.9) | .87 |
| Social functioning | 71.9 (25.2) | 58.7 (27.1) | 65.30 (26.9) | .004 |
| EORTC QLQ-H&N35 (mean, SD) | ||||
| Sexuality subscale | 39.6 (34.6) | 51.7 (33.6) | 45.65 (34.5) | .040 |
| Unmet sexual health need (sexuality subscale > 10) | .068 | |||
| Yes | 46 (68.7%) | 56 (83.6%) | 102 (76.1%) | |
| No | 21 (31.3%) | 11 (16.4%) | 32 (23.9%) |
| Patient characteristic . | Intervention (N = 67) . | Control (N = 67) . | Total (N = 134) . | P-value . |
|---|---|---|---|---|
| Age (mean, SD) | 62.5 (8.5) | 61.1 (9.9) | 61.8 (9.2) | .37 |
| Gender | .86 | |||
| Men | 44 (65.7%) | 42 (62.7%) | 86 (64.2%) | |
| Women | 23 (34.3%) | 25 (37.3%) | 48 (35.8%) | |
| Paid job | .86 | |||
| Yes | 22 (32.8%) | 24 (35.8%) | 46 (34.3%) | |
| No | 45 (67.2%) | 43 (64.2%) | 88 (65.7%) | |
| Marital status | .57 | |||
| Married/living together | 49 (73.1%) | 45 (67.2%) | 94 (70.1%) | |
| Unmarried/divorced/widowed | 18 (26.9%) | 22 (32.8%) | 40 (29.9%) | |
| Years of education | .29 | |||
| 5-10 | 33 (49.3%) | 24 (35.8%) | 57 (42.5%) | |
| 11-16 | 30 (44.7%) | 38 (56.7%) | 68 (50.8%) | |
| 17-21 | 4 (6.0%) | 5 (7.5%) | 9 (6.7%) | |
| Tumor location | .079 | |||
| Lip/oral/cavity/oropharynx | 29 (43.3%) | 42 (62.7%) | 71 (53%) | |
| Hypopharynx/larynx | 21 (31.3%) | 14 (20.9%) | 35 (26.1%) | |
| Other head and neck cancers | 17 (25.4%) | 11 (16.4%) | 28 (20.9%) | |
| Tumor stage | .22 | |||
| Unknown | 7 (10.4%) | 2 (3.0%) | 9 (6.7%) | |
| I | 13 (19.4%) | 17 (25.4%) | 30 (22.4%) | |
| II | 15 (22.4%) | 9 (13.4%) | 24 (17.9%) | |
| III | 9 (13.4%) | 13 (19.4%) | 22 (16.4%) | |
| IV | 23 (43.3%) | 26 (38.8%) | 49 (36.6%) | |
| Tumor treatment | .005 | |||
| Surgery | 11 (16.4%) | 19 (28.4%) | 30 (22.4%) | |
| Radiotherapy | 22 (32.8%) | 12 (17.9%) | 34 (25.4%) | |
| Chemoradiation | 5 (7.5%) | 18 (26.9%) | 23 (17.2%) | |
| Surgery + radiotherapy | 25 (37.3%) | 14 (20.9%) | 39 (29.1%) | |
| Surgery + chemoradiation | 4 (6.0%) | 3 (4.4%) | 7 (5.2%) | |
| Surgery + chemotherapy | 0 | 1 (1.5%) | 1 (0.7%) | |
| Time since treatment | .65 | |||
| >7 months | 26 (38.8%) | 23 (34.3%) | 49 (36.6%) | |
| 7-12 months | 10 (14.9%) | 14 (20.9%) | 24 (17.9%) | |
| >12 months | 31 (46.3%) | 30 (44.8%) | 61 (45.5%) | |
| Anxiety or depression disorder (CIDI) | .42 | |||
| Yes | 14 (20.9%) | 19 (28.4%) | 33 (24.6%) | |
| No | 53 (79.1%) | 48 (71.6%) | 101 (75.4%) | |
| HADS (mean, SD) | ||||
| Total | 17.5 (5.2) | 19.5 (5.8) | 18.5 (5.6) | .030 |
| Depression | 8.28 (3.6) | 9.96 (3.7) | 9.62 (3.6) | .009 |
| Anxiety | 9.18 (3.6) | 9.58 (3.7) | 9.38 (3.7) | .53 |
| EORTC QLQ-C30 (mean, SD) | ||||
| Global quality of life | 59.5 (19.8) | 55.5 (19.5) | 57.46 (19.7) | .24 |
| Physical functioning | 71.6 (20.9) | 70.7 (20.8) | 71.16 (20.8) | .79 |
| Role functioning | 62.2 (26.7) | 55.5 (26.0) | 58.83 (26.5) | .14 |
| Emotional functioning | 58.3 (26.1) | 56.3 (22.6) | 57.30 (24.3) | .65 |
| Cognitive functioning | 71.4 (27.3) | 70.6 (24.5) | 71.02 (25.9) | .87 |
| Social functioning | 71.9 (25.2) | 58.7 (27.1) | 65.30 (26.9) | .004 |
| EORTC QLQ-H&N35 (mean, SD) | ||||
| Sexuality subscale | 39.6 (34.6) | 51.7 (33.6) | 45.65 (34.5) | .040 |
| Unmet sexual health need (sexuality subscale > 10) | .068 | |||
| Yes | 46 (68.7%) | 56 (83.6%) | 102 (76.1%) | |
| No | 21 (31.3%) | 11 (16.4%) | 32 (23.9%) |
Significant differences (P < .05) are presented in bold font.
SD = standard deviation; CIDI = Composite International Diagnostic Interview; HADS = Hospital Anxiety and Depression Scale; EORTC QLQ-C30 = European Organization for Research and Treatment of Cancer, Qualify of Life Questionnaire; H&N35 = head and neck specific module.
| Patient characteristic . | Intervention (N = 67) . | Control (N = 67) . | Total (N = 134) . | P-value . |
|---|---|---|---|---|
| Age (mean, SD) | 62.5 (8.5) | 61.1 (9.9) | 61.8 (9.2) | .37 |
| Gender | .86 | |||
| Men | 44 (65.7%) | 42 (62.7%) | 86 (64.2%) | |
| Women | 23 (34.3%) | 25 (37.3%) | 48 (35.8%) | |
| Paid job | .86 | |||
| Yes | 22 (32.8%) | 24 (35.8%) | 46 (34.3%) | |
| No | 45 (67.2%) | 43 (64.2%) | 88 (65.7%) | |
| Marital status | .57 | |||
| Married/living together | 49 (73.1%) | 45 (67.2%) | 94 (70.1%) | |
| Unmarried/divorced/widowed | 18 (26.9%) | 22 (32.8%) | 40 (29.9%) | |
| Years of education | .29 | |||
| 5-10 | 33 (49.3%) | 24 (35.8%) | 57 (42.5%) | |
| 11-16 | 30 (44.7%) | 38 (56.7%) | 68 (50.8%) | |
| 17-21 | 4 (6.0%) | 5 (7.5%) | 9 (6.7%) | |
| Tumor location | .079 | |||
| Lip/oral/cavity/oropharynx | 29 (43.3%) | 42 (62.7%) | 71 (53%) | |
| Hypopharynx/larynx | 21 (31.3%) | 14 (20.9%) | 35 (26.1%) | |
| Other head and neck cancers | 17 (25.4%) | 11 (16.4%) | 28 (20.9%) | |
| Tumor stage | .22 | |||
| Unknown | 7 (10.4%) | 2 (3.0%) | 9 (6.7%) | |
| I | 13 (19.4%) | 17 (25.4%) | 30 (22.4%) | |
| II | 15 (22.4%) | 9 (13.4%) | 24 (17.9%) | |
| III | 9 (13.4%) | 13 (19.4%) | 22 (16.4%) | |
| IV | 23 (43.3%) | 26 (38.8%) | 49 (36.6%) | |
| Tumor treatment | .005 | |||
| Surgery | 11 (16.4%) | 19 (28.4%) | 30 (22.4%) | |
| Radiotherapy | 22 (32.8%) | 12 (17.9%) | 34 (25.4%) | |
| Chemoradiation | 5 (7.5%) | 18 (26.9%) | 23 (17.2%) | |
| Surgery + radiotherapy | 25 (37.3%) | 14 (20.9%) | 39 (29.1%) | |
| Surgery + chemoradiation | 4 (6.0%) | 3 (4.4%) | 7 (5.2%) | |
| Surgery + chemotherapy | 0 | 1 (1.5%) | 1 (0.7%) | |
| Time since treatment | .65 | |||
| >7 months | 26 (38.8%) | 23 (34.3%) | 49 (36.6%) | |
| 7-12 months | 10 (14.9%) | 14 (20.9%) | 24 (17.9%) | |
| >12 months | 31 (46.3%) | 30 (44.8%) | 61 (45.5%) | |
| Anxiety or depression disorder (CIDI) | .42 | |||
| Yes | 14 (20.9%) | 19 (28.4%) | 33 (24.6%) | |
| No | 53 (79.1%) | 48 (71.6%) | 101 (75.4%) | |
| HADS (mean, SD) | ||||
| Total | 17.5 (5.2) | 19.5 (5.8) | 18.5 (5.6) | .030 |
| Depression | 8.28 (3.6) | 9.96 (3.7) | 9.62 (3.6) | .009 |
| Anxiety | 9.18 (3.6) | 9.58 (3.7) | 9.38 (3.7) | .53 |
| EORTC QLQ-C30 (mean, SD) | ||||
| Global quality of life | 59.5 (19.8) | 55.5 (19.5) | 57.46 (19.7) | .24 |
| Physical functioning | 71.6 (20.9) | 70.7 (20.8) | 71.16 (20.8) | .79 |
| Role functioning | 62.2 (26.7) | 55.5 (26.0) | 58.83 (26.5) | .14 |
| Emotional functioning | 58.3 (26.1) | 56.3 (22.6) | 57.30 (24.3) | .65 |
| Cognitive functioning | 71.4 (27.3) | 70.6 (24.5) | 71.02 (25.9) | .87 |
| Social functioning | 71.9 (25.2) | 58.7 (27.1) | 65.30 (26.9) | .004 |
| EORTC QLQ-H&N35 (mean, SD) | ||||
| Sexuality subscale | 39.6 (34.6) | 51.7 (33.6) | 45.65 (34.5) | .040 |
| Unmet sexual health need (sexuality subscale > 10) | .068 | |||
| Yes | 46 (68.7%) | 56 (83.6%) | 102 (76.1%) | |
| No | 21 (31.3%) | 11 (16.4%) | 32 (23.9%) |
| Patient characteristic . | Intervention (N = 67) . | Control (N = 67) . | Total (N = 134) . | P-value . |
|---|---|---|---|---|
| Age (mean, SD) | 62.5 (8.5) | 61.1 (9.9) | 61.8 (9.2) | .37 |
| Gender | .86 | |||
| Men | 44 (65.7%) | 42 (62.7%) | 86 (64.2%) | |
| Women | 23 (34.3%) | 25 (37.3%) | 48 (35.8%) | |
| Paid job | .86 | |||
| Yes | 22 (32.8%) | 24 (35.8%) | 46 (34.3%) | |
| No | 45 (67.2%) | 43 (64.2%) | 88 (65.7%) | |
| Marital status | .57 | |||
| Married/living together | 49 (73.1%) | 45 (67.2%) | 94 (70.1%) | |
| Unmarried/divorced/widowed | 18 (26.9%) | 22 (32.8%) | 40 (29.9%) | |
| Years of education | .29 | |||
| 5-10 | 33 (49.3%) | 24 (35.8%) | 57 (42.5%) | |
| 11-16 | 30 (44.7%) | 38 (56.7%) | 68 (50.8%) | |
| 17-21 | 4 (6.0%) | 5 (7.5%) | 9 (6.7%) | |
| Tumor location | .079 | |||
| Lip/oral/cavity/oropharynx | 29 (43.3%) | 42 (62.7%) | 71 (53%) | |
| Hypopharynx/larynx | 21 (31.3%) | 14 (20.9%) | 35 (26.1%) | |
| Other head and neck cancers | 17 (25.4%) | 11 (16.4%) | 28 (20.9%) | |
| Tumor stage | .22 | |||
| Unknown | 7 (10.4%) | 2 (3.0%) | 9 (6.7%) | |
| I | 13 (19.4%) | 17 (25.4%) | 30 (22.4%) | |
| II | 15 (22.4%) | 9 (13.4%) | 24 (17.9%) | |
| III | 9 (13.4%) | 13 (19.4%) | 22 (16.4%) | |
| IV | 23 (43.3%) | 26 (38.8%) | 49 (36.6%) | |
| Tumor treatment | .005 | |||
| Surgery | 11 (16.4%) | 19 (28.4%) | 30 (22.4%) | |
| Radiotherapy | 22 (32.8%) | 12 (17.9%) | 34 (25.4%) | |
| Chemoradiation | 5 (7.5%) | 18 (26.9%) | 23 (17.2%) | |
| Surgery + radiotherapy | 25 (37.3%) | 14 (20.9%) | 39 (29.1%) | |
| Surgery + chemoradiation | 4 (6.0%) | 3 (4.4%) | 7 (5.2%) | |
| Surgery + chemotherapy | 0 | 1 (1.5%) | 1 (0.7%) | |
| Time since treatment | .65 | |||
| >7 months | 26 (38.8%) | 23 (34.3%) | 49 (36.6%) | |
| 7-12 months | 10 (14.9%) | 14 (20.9%) | 24 (17.9%) | |
| >12 months | 31 (46.3%) | 30 (44.8%) | 61 (45.5%) | |
| Anxiety or depression disorder (CIDI) | .42 | |||
| Yes | 14 (20.9%) | 19 (28.4%) | 33 (24.6%) | |
| No | 53 (79.1%) | 48 (71.6%) | 101 (75.4%) | |
| HADS (mean, SD) | ||||
| Total | 17.5 (5.2) | 19.5 (5.8) | 18.5 (5.6) | .030 |
| Depression | 8.28 (3.6) | 9.96 (3.7) | 9.62 (3.6) | .009 |
| Anxiety | 9.18 (3.6) | 9.58 (3.7) | 9.38 (3.7) | .53 |
| EORTC QLQ-C30 (mean, SD) | ||||
| Global quality of life | 59.5 (19.8) | 55.5 (19.5) | 57.46 (19.7) | .24 |
| Physical functioning | 71.6 (20.9) | 70.7 (20.8) | 71.16 (20.8) | .79 |
| Role functioning | 62.2 (26.7) | 55.5 (26.0) | 58.83 (26.5) | .14 |
| Emotional functioning | 58.3 (26.1) | 56.3 (22.6) | 57.30 (24.3) | .65 |
| Cognitive functioning | 71.4 (27.3) | 70.6 (24.5) | 71.02 (25.9) | .87 |
| Social functioning | 71.9 (25.2) | 58.7 (27.1) | 65.30 (26.9) | .004 |
| EORTC QLQ-H&N35 (mean, SD) | ||||
| Sexuality subscale | 39.6 (34.6) | 51.7 (33.6) | 45.65 (34.5) | .040 |
| Unmet sexual health need (sexuality subscale > 10) | .068 | |||
| Yes | 46 (68.7%) | 56 (83.6%) | 102 (76.1%) | |
| No | 21 (31.3%) | 11 (16.4%) | 32 (23.9%) |
Significant differences (P < .05) are presented in bold font.
SD = standard deviation; CIDI = Composite International Diagnostic Interview; HADS = Hospital Anxiety and Depression Scale; EORTC QLQ-C30 = European Organization for Research and Treatment of Cancer, Qualify of Life Questionnaire; H&N35 = head and neck specific module.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
